Effects of initial and long-term lipid-lowering therapy on vascular wall characteristics

被引:21
作者
Ubels, FL
Muntinga, JHJ
van Doormaal, JJ
Reitsma, WD
Smit, AJ
机构
[1] Univ Groningen Hosp, Dept Internal Med, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, Dept Med Physiol, NL-9712 KZ Groningen, Netherlands
[3] Univ Groningen Hosp, Out Patient Clin Atherosclerosis Lipid Disorders, Dept Cardiol, NL-9700 RB Groningen, Netherlands
关键词
hypercholesterolaemia; lipid-lowering drugs; 3 hydroxy-3-methylglutaryl-coenzyme reductase inhibitor; clinical trial; intima-media thickness; vascular wall;
D O I
10.1016/S0021-9150(00)00450-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several studies have demonstrated the beneficial effects of 3 hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors on vascular properties, but little is known about treatment intensification. We compared patients in whom statins were started (INITIAL, n = 30) for hypercholesterolaemia (>6.5 mmol l(-1)) with a matched patient group of long-time statin users, with similar baseline characteristics for lipids, intima-media thickness (IMT), and pulse wave velocity, in whom treatment with statins was intensified (LONG-TERM, n = 54). At baseline and after 1 year, lipid profile, IMT of the carotid and femoral arteries, aortic distensibility using pulse-wave velocity and various properties of the peripheral vascular bed using a recently developed bio-impedance method were measured. After 1 year the relative changes in lipid profile were significantly better in the INITIAL compared with the LONG-TERM-group, The relative changes in IMT of the mean internal carotid and common femoral arteries significantly differed between the INITIAL and LONG-TERM-group (-8 and +11%, -11 and +22%, respectively). After 1 year, in both groups, most other vascular wall characteristics were unaltered compared with baseline. In conclusion, the beneficial structural alterations of the vascular wall were greater after starting than after intensifying already existing lipid-lowering treatment. This suggests that other effects of HMG-CoA reductase inhibitors than lipid-lowering alone must be involved in vascular changes. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:155 / 161
页数:7
相关论文
共 26 条
[1]   B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: A report of the regression growth evaluation statin study (REGRESS) [J].
de Groot, E ;
Jukema, JW ;
van Swijndregt, ADM ;
Zwinderman, AH ;
Ackerstaff, RGA ;
van der Steen, AFW ;
Bom, N ;
Lie, KI ;
Bruschke, AVG .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (07) :1561-1567
[2]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[3]   Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness [J].
Hodis, HN ;
Mack, WJ ;
Dunn, M ;
Liu, CR ;
Selzer, RH ;
Krauss, RM .
CIRCULATION, 1997, 95 (08) :2022-2026
[4]   CAROTID-ARTERY INTIMAL-MEDIAL THICKNESS DISTRIBUTION IN GENERAL POPULATIONS AS EVALUATED BY B-MODE ULTRASOUND [J].
HOWARD, G ;
SHARRETT, AR ;
HEISS, G ;
EVANS, GW ;
CHAMBLESS, LE ;
RILEY, WA ;
BURKE, GL .
STROKE, 1993, 24 (09) :1297-1304
[5]   Comparative dose efficacy study of Atorvastatin versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in patients with hypercholesterolemia (The CURVES study) [J].
Jones, P ;
Kafonek, S ;
Laurora, I ;
Hunninghake, D .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (05) :582-587
[6]  
JOURNEE HL, 1994, EUR J ULTRASOUND, V1, pS33
[7]   Drug treatment of lipid disorders [J].
Knopp, RH .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (07) :498-511
[8]  
Laogun A A, 1982, Clin Phys Physiol Meas, V3, P201, DOI 10.1088/0143-0815/3/3/004
[9]  
LUBBERS J, 1994, EUR J ULTRASOUND, V1, pS32
[10]   Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the stanford coronary risk intervention project [J].
Miller, BD ;
Alderman, EL ;
Haskell, WL ;
Fair, JM ;
Krauss, RM .
CIRCULATION, 1996, 94 (09) :2146-2153